Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:
fondaparinux
fondaparinux
| Drug Name | Form | Strength | Non-Formulary | Restricted | Renal Dosing | REMS | Therapeutic Interchange | Notes |
|---|---|---|---|---|---|---|---|---|
| Arixtra | SOLUTION, SUBCUTANEOUS | 2.5 mg/0.5 mL | ||||||
| Fondaparinux | SOLUTION, SUBCUTANEOUS | 2.5 mg/0.5 mL | ||||||
| Arixtra | SOLUTION, SUBCUTANEOUS | 5 mg/0.4 mL | ||||||
| Fondaparinux | SOLUTION, SUBCUTANEOUS | 5 mg/0.4 mL | ||||||
| Fondaparinux | SOLUTION, SUBCUTANEOUS | 7.5 mg/0.6 mL | ||||||
| Arixtra | SOLUTION, SUBCUTANEOUS | 10 mg/0.8 mL | ||||||
| Fondaparinux | SOLUTION, SUBCUTANEOUS | 10 mg/0.8 mL |
Last updated: Aug. 22, 2022
- Black Box Warning: Spinal/epidural hematoma risk
Rhazdrugs: fondaparinux
fondaparinux